Analysis of adaptive immune cell populations showed that VVL-TD-mIL-27 treatment significantly increased the proportion of CD8+ TEM in tumor tissues, and this effect was also observed in spleens at day 12, suggesting that the immune response induced by viral therapy extended from the tumor local to the whole body. This evidence concerns the gene CD8A and neoplasm.